These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 14486033)

  • 41. CHANGES IN SERUM LIPOPROTEINS AFTER A LARGE FAT MEAL IN NORMAL INDIVIDUALS AND IN PATIENTS WITH ISCHEMIC HEART DISEASE.
    HARLAN WR; BEISCHER DE
    Am Heart J; 1963 Jul; 66():61-7. PubMed ID: 14045989
    [No Abstract]   [Full Text] [Related]  

  • 42. Dietary influence on molecular distribution of serum lipoproteins in subjects with proven coronary artery disease.
    Bahler RC; Opplt JJ
    Adv Exp Med Biol; 1977; 82():195-7. PubMed ID: 200090
    [No Abstract]   [Full Text] [Related]  

  • 43. Direct determination of lipoprotein cholesterol distribution with micro-scale affinity chromatography columns.
    Bentzen CL; Acuff KJ; Marechal B; Rosenthal MA; Volk ME
    Clin Chem; 1982 Jul; 28(7):1451-6. PubMed ID: 7083554
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cholesterol Levels of Six Fractionated Serum Lipoproteins and its Relevance to Coronary Heart Disease Risk Scores.
    Manita D; Yoshida H; Hirowatari Y
    J Atheroscler Thromb; 2017 Sep; 24(9):928-939. PubMed ID: 28025448
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk.
    Walldius G; Jungner I; Aastveit AH; Holme I; Furberg CD; Sniderman AD
    Clin Chem Lab Med; 2004; 42(12):1355-63. PubMed ID: 15576296
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lipoprotein(a), cholesterol, and coronary heart diseases.
    Ghilain JM; Parfonry A; Kozyreff V; Heller FR
    Lancet; 1988 Oct; 2(8617):963. PubMed ID: 2902408
    [No Abstract]   [Full Text] [Related]  

  • 47. [Various lipoprotein fractions and their relation to ischemic heart disease].
    Palazzuoli V; Mondillo S; Kristodhullu A; De Stefano R; Amatucci G
    G Ital Cardiol; 1983; 13(2):90-4. PubMed ID: 6884650
    [TBL] [Abstract][Full Text] [Related]  

  • 48. LIPIDS IN NORMALS AND PATIENTS WITH CORONARY ARTERY DISEASE.
    KROMAN H; NODINE J; BENDER S; BREST A
    Am J Med Sci; 1964 Nov; 248():571-80. PubMed ID: 14224777
    [No Abstract]   [Full Text] [Related]  

  • 49. RISK FACTORS IN CORONARY HEART DISEASE. AN EVALUATION OF SEVERAL SERUM LIPIDS AS PREDICTORS OF CORONARY HEART DISEASE; THE FRAMINGHAM STUDY.
    KANNEL WB; DAWBER TR; FRIEDMAN GD; GLENNON WE; MCNAMARA PM
    Ann Intern Med; 1964 Nov; 61():888-99. PubMed ID: 14233810
    [No Abstract]   [Full Text] [Related]  

  • 50. Impact of Remnant Lipoprotein on Coronary Plaque Components.
    Matsuo N; Matsuoka T; Onishi S; Yamamoto H; Kato A; Makino Y; Kihara S
    J Atheroscler Thromb; 2015 Aug; 22(8):783-95. PubMed ID: 25739822
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Abnormalities in serum lipoprotein composition in patients with premature coronary heart disease compared to serum lipid matched controls.
    Pauciullo P; Rubba P; Marotta G; Carbone C; Cortese C; Caruso MG; Spampinato N; Mancini M
    Atherosclerosis; 1988 Oct; 73(2-3):241-6. PubMed ID: 3190821
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association of cholesterol concentrations in low-density lipoprotein, high-density lipoprotein, and high-density lipoprotein subfractions, and of apolipoproteins AI and AII, with coronary stenosis and left ventricular function.
    Kempen HJ; van Gent CM; Buytenhek R; Buis B
    J Lab Clin Med; 1987 Jan; 109(1):19-26. PubMed ID: 3098880
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relationship between smoking and cardiovascular risk factors in the development of peripheral arterial disease and coronary artery disease: Edinburgh Artery Study.
    Price JF; Mowbray PI; Lee AJ; Rumley A; Lowe GD; Fowkes FG
    Eur Heart J; 1999 Mar; 20(5):344-53. PubMed ID: 10206381
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Relation of angiographically defined coronary artery disease to plasma lipoprotein subfractions and apolipoproteins.
    Miller NE; Hammett F; Saltissi S; Rao S; van Zeller H; Coltart J; Lewis B
    Br Med J (Clin Res Ed); 1981 May; 282(6278):1741-4. PubMed ID: 6786600
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Triglyceride-rich lipoproteins as risk factors for atherosclerosis].
    Schwandt P
    Klin Wochenschr; 1990; 68 Suppl 22():54-8. PubMed ID: 2087080
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Diabetic dyslipidaemia.
    Erkelens DW
    Eur Heart J; 1998 Jul; 19 Suppl H():H27-40. PubMed ID: 9717062
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Improved identification of patients with coronary artery disease by the use of new lipid and lipoprotein biomarkers.
    Johnston N; Jernberg T; Lagerqvist B; Siegbahn A; Wallentin L
    Am J Cardiol; 2006 Mar; 97(5):640-5. PubMed ID: 16490429
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Plasma lipids and coronary atherosclerosis in Japanese men.
    Nakaya Y; Hiasa Y; Morimoto S
    Tokushima J Exp Med; 1993 Dec; 40(3-4):177-82. PubMed ID: 8184414
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serum triglyceride and lipoprotein cholesterol in male survivor of ischaemic heart disease in eastern Uttar Pradesh (north India).
    Kabi BC; Somani PN; Koteswara Rao GR
    Indian Heart J; 1985; 37(3):176-8. PubMed ID: 4065916
    [No Abstract]   [Full Text] [Related]  

  • 60. Influence of plasma triglycerides on lipoprotein patterns in normal subjects and in patients with coronary artery disease.
    Richards EG; Grundy SM; Cooper K
    Am J Cardiol; 1989 May; 63(17):1214-20. PubMed ID: 2711991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.